Understanding what changes, and why, matters before you decide how to handle social drinking while on treatment
When administered as a once-daily subcutaneous injection, Saxenda acts on several mechanisms to promote weight loss: Appetite suppression : It acts on areas of the brain that regulate appetite, helping patients feel fuller for longer periods Delayed gastric emptying : The medication slows the rate at which food leaves the stomach, contributing to prolonged satiety Improved glucose regulation : It enhances insulin secretion when blood glucose levels are elevated According to the Summary of Product Characteristics (SmPC), Saxenda is licensed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater in the presence of weight-related comorbidities such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea
Not at the high doses you see in weight loss clinics, but at lower doses combined with comprehensive psychological and lifestyle support
Most weight loss experts recommend 0.7 to 1.0 grams of protein per pound of goal body weight daily while on GLP-1 medications
doi: 10.1016/j.jad.2016.09.056 13 KuchayMSKrishanSMishraSKChoudharyNSSinghMKWasirJSet al
It took the FDA until 2004 to warn about this worrisome complication